Phreesia, Inc. (PHR)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 125 | 149 | 213 | 281 | 356 | 420 | 481 | 508 |
| Operating profit | $m | -7 | 16 | ||||||
| Net profit | $m | -20 | -27 | -118 | -176 | -137 | -59 | 2 | 10 |
| EPS reported | $ | 0.04 | 0.17 | ||||||
| Operating cashflow per share | $ | 1.32 | 1.44 | ||||||
| Capex per share | $ | 0.19 | 0.25 | ||||||
| FCF per share | $ | 1.13 | 1.19 | ||||||
| Free cash flow | $m | 68 | 78 | ||||||
| Net debt | $m | 19 | -6 | ||||||
| Book value equity | $m | 337 | 372 | ||||||
| Book value per share | $ | 5.48 | 5.95 | ||||||
| Number of shares | m | 61.49 | 62.46 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 34.16 | 67.83 | ||||||
| P/B LTM | x | 2.38 | 4.41 | ||||||
| P/S LTM | x | 1.22 | 3.23 | ||||||
| P/FCF LTM | x | 11.85 | 21.15 | ||||||
| EV/EBITDA LTM | x | 13.99 | 27.91 | ||||||
| EV/Sales LTM | x | 1.61 | 1.57 | ||||||
| Earnings Yield LTM | % | +3.15% | +1.47% | ||||||
| FCF Yield | % | +8.44% | +4.73% | ||||||
| Quality | |||||||||
| ROE | % | +0.68% | +2.79% | ||||||
| ROIC | % | +0.35% | -6.19% | ||||||
| Operating margin | % | -1.38% | +0.73% | ||||||
| Gross margin | % | +67.93% | +65.81% | ||||||
| FCF/Sales | % | +14.09% | +14.68% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +14.48% | +42.52% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | +716.61% | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.66 | 1.14 | ||||||
| Net Debt/EBITDA | x | 0.97 | 0.42 | ||||||
| EBIT/Net interest | x | -0.95 | 0.39 | ||||||
| Net debt/market cap | % | +11.55% | +11.66% | ||||||
| Net debt/Equity | x | 0.06 | -0.02 | ||||||
| Gross debt/equity | x | 0.30 | 0.18 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free